Clinical Data Management Built Around Biotech Companies
Evestia Clinical operates as an extension of the sponsor organization. Sponsors work directly with Clinical Data Managers with Phase I–IV & Post-Marketing expertise across complex therapeutic areas, alongside integrated Biostatistics collaboration and submission-focused quality processes throughout the study lifecycle. Every data management activity, from database design through to database lock, is coordinated as one integrated program that produces reliable clinical evidence supporting confident development decisions and stronger regulatory submissions. Collaboration is structured around each sponsor's scientific objectives, regulatory timelines and therapeutic requirements, with the same team engaged from first patient visit through to final dataset delivery.
Experienced Clinical Data Managers
Clinical Data Managers with Phase I–IV & Post-Marketing expertise across complex therapeutic areas, working as an integrated extension of sponsor teams.
Integrated Biostatistics
CDM and Biostatistics working in alignment throughout development, from SAP input to CDISC-compliant submission datasets.
Submission-focused planning
Quality processes designed around regulatory submission requirements from database design through to final dataset delivery.
Flexible delivery models
Full-Service CRO or embedded FSP resource, scaled to program requirements without expanding sponsor headcount.
Clinical Data Management Expertise
Phase I–IV & Post-Marketing experience, integrated Biostatistics capability and therapeutic expertise across oncology, rare disease and advanced therapies, delivering submission-ready clinical evidence across the most complex development programs.
Phase I–IV
Clinical Data Support
First-in-human to post-marketing
30+ Years
Combined Data Expertise
Strengthened through specialist scientific teams
Submission-Ready
Clinical Datasets
Supporting regulatory submissions
Integrated
Biostatistics Capability
End-to-end data and statistical support
Expert Clinical Data Management Supporting Reliable Clinical Development Decisions
Reliable clinical evidence drives confident development decisions. Evestia Clinical helps sponsors deliver reliable, complete and submission-ready clinical datasets throughout every stage of development through integrated data management across every site, data source and regulatory jurisdiction.
These capabilities sit within our integrated Full-Service CRO model, working directly alongside Medical Affairs, Clinical Operations, Clinical Trial Management and Biostatistics. As a Biotech CRO, Evestia Clinical understands the resource pressures emerging companies face when managing complex clinical datasets, delivering reliable, analysis-ready evidence that withstands regulatory scrutiny.
Why Clinical Data Management Matters
Data quality is a direct driver of program success. Clean, well-managed data gives sponsors and regulators confidence in every decision that follows, from analysis and safety reporting through to the development decisions that determine program progression.
Across Phase I, Phase II and Phase III development, reliable clinical evidence supports confident decision-making and regulatory readiness. Clinical Data Management works in alignment with Medical Affairs, Regulatory Affairs, Biostatistics and Pharmacovigilance to build submissions on data that is accurate, complete and regulatory-compliant from first patient enrolled.
Expertise Built for Modern Clinical Development
Modern clinical trials generate increasingly rich and diverse datasets that provide valuable scientific insight when supported by experienced Clinical Data Management. Data flows from investigator sites, central laboratories, imaging providers, wearable devices, patient-reported outcomes and electronic health records simultaneously.
Regulatory expectations have evolved in parallel. Agencies increasingly expect sponsors to demonstrate robust data governance, CDISC-compliant datasets and audit-ready documentation throughout development, not only at submission.
Clinical Data Management specialists work closely with Medical Affairs, Clinical Operations, Clinical Trial Management, Regulatory Affairs and Biostatistics teams to provide integrated support across every stage of development, turning rich data into confident regulatory submissions.
Clinical Data Management is the scientific discipline that transforms raw clinical information into reliable evidence. It is the foundation for statistical analysis and regulatory submissions, supporting data quality throughout the clinical development lifecycle.
Clinical Data Management provides the scientific foundation for development decisions, statistical analysis and regulatory submissions, with accurate, complete and traceable data supporting every stage of the clinical program. Clinical Data Management activities include:
The Value of Expert Clinical Data Management
Data quality throughout development supports the regulatory submissions, investor confidence and development milestones that program success depends on.
Better Development Decisions
Reliable clinical data supports timely, informed development decisions throughout the program lifecycle. Accurate, well-managed datasets give sponsors the clarity needed for analysis, safety reporting and the investment decisions that determine program progression.
Regulatory Readiness
Regulatory submissions depend on datasets that are accurate, complete and consistently coded. Structured data management, CDISC-compliant preparation and rigorous quality processes strengthen submission readiness and improve the confidence regulators can place in the data.
Faster, Informed Decision-Making
Clean, well-managed data gives sponsors greater operational visibility throughout the study. Rather than discovering issues at database lock, continuous review keeps leadership informed and program decisions grounded in reliable evidence.
Proactive Data Quality Management
Continuous data review, proactive cleaning and rigorous validation sustain dataset quality throughout development, supporting timelines, submission quality and the board confidence that program success depends on.
Submission Success
Regulatory agencies expect high-quality, analysis-ready datasets from the outset. Investment in data quality throughout development supports successful regulatory submissions through well-prepared, analysis-ready datasets.
Our Clinical Data Management Services
Each service is delivered as part of an integrated approach designed around program outcomes and regulatory submission requirements, supporting confident decision-making throughout development.
Database Design and Build
Well-designed databases improve data capture quality from the first patient visit and establish the foundation for reliable clinical evidence. Well-structured Case Report Forms and database specifications aligned with protocol requirements support accurate, efficient data collection throughout the study.
- Case Report Form (CRF) design
- Database specification development
- Database build
- Validation testing
- User acceptance testing
Databases designed for quality from the outset support clean data throughout the study lifecycle and smoother regulatory submissions.
Electronic Data Capture (EDC) Management
Efficient EDC configuration gives sponsors better study visibility, faster data access and improved site usability. Our teams support a range of leading EDC platforms including Medidata Rave, Veeva Vault CDMS and Zelta by Merative, providing flexible expertise aligned with sponsor system preferences.
- EDC configuration
- User management
- Validation support
- System maintenance
- Ongoing optimization
Data Validation and Cleaning
Continuous validation and proactive data cleaning maintain reliable datasets throughout development. Issues are identified and resolved as they arise, supporting analysis timelines, regulatory submissions and the dataset quality that development decisions depend on.
- Data review
- Data cleaning
- Query generation
- Query resolution support
- Quality control checks
Continuous data review sustains dataset quality throughout the study and reduces the burden of late-stage data corrections.
Medical Coding
Consistent medical coding supports reliable safety analysis, pharmacovigilance and regulatory reporting. Our teams apply MedDRA and WHODrug standards to ensure every term is classified correctly, supporting defensible regulatory submissions and meaningful safety signal detection. Additional terminology and coding systems can be supported as required.
- MedDRA coding
- WHODrug coding
- Coding review
- Coding reconciliation
- Additional coding systems (editable, add as approved)
Accurate, consistent coding supports reliable safety signal detection and smoother regulatory review at submission. Additional terminology systems can be added as approved information is supplied.
Data Reconciliation
Modern clinical trials generate data from multiple sources: laboratories, imaging vendors, safety databases, wearable devices and patient-reported outcomes. Integrating these data sources accurately and consistently requires experienced oversight. Our teams coordinate reconciliation across all vendor datasets to give sponsors confidence in the completeness of their clinical data.
- Laboratory data
- Safety data
- Imaging data
- Vendor datasets
- External data integrations
Structured reconciliation across all data sources ensures completeness and consistency before statistical analysis begins.
Database Lock and Study Close-Out
Structured database lock preparation supports timely statistical analysis and submission-ready datasets. Coordinated closely with Biostatistics teams, lock preparation ensures datasets are analysis-ready and submission-quality from the moment lock is executed.
- Final data review
- Data reconciliation
- Quality checks
- Database lock preparation
- Lock execution
Well-prepared database lock supports statistical analysis timelines and keeps regulatory submissions on schedule.
How Evestia Strengthens Clinical Data Management
Integrated Clinical Data Management keeps programs moving, with data priorities managed proactively so development decisions, regulatory timelines and program confidence are supported throughout the study.
Data Quality
Proactive validation, continuous cleaning and rigorous quality oversight sustain the reliable, complete and submission-ready clinical datasets that development decisions and regulatory submissions depend on.
Submission Readiness
Structured data management, specialist coding and submission-focused quality processes keep datasets CDISC-compliant and analysis-ready, supporting smooth regulatory review when program momentum matters most.
Multiple Data Sources
Modern clinical trials integrate data from investigator sites, central laboratories, imaging vendors, patient-reported outcome platforms and wearable devices. Experienced data reconciliation across all sources gives sponsors confidence in the completeness of their clinical evidence.
Operational Visibility
Continuous data review and proactive query management give clinical development leadership the reliable, timely study visibility they need to manage programs and communicate progress to investors and boards.
Regulatory Compliance
Consistent quality management, audit-ready documentation and inspection-ready data practices keep programs well-positioned for regulatory review throughout the development lifecycle.
Extended CDM Capacity
Experienced Clinical Data Management specialists provide the technical depth and regulatory knowledge sponsors need, alongside scientific and commercial priorities, without requiring permanent headcount expansion.
Clinical Data Management Across Every Phase of Development
Data management priorities evolve as studies grow in complexity, patient populations expand and regulatory stakes intensify. CDM strategies are adapted to each phase rather than applying a single standard approach across all programs.
Early-stage studies demand rapid data review and safety reporting to support dose-escalation decisions and first-in-human safety assessments. Data quality at Phase I directly influences the development decisions that determine whether a program progresses. Our CDM teams provide the responsive oversight and rapid turnaround that early-stage innovation requires.
Learn morePhase II introduces expanding patient populations, increasing data complexity and proof-of-concept endpoints that drive funding decisions. Data management strategies must scale as programs grow without compromising quality. Our teams maintain data integrity and operational visibility as site networks expand and data volumes increase.
Learn moreLarge multinational registration studies generate significant data volumes from dozens of sites across multiple regulatory jurisdictions. Submission-quality data, consistent coding and CDISC-compliant datasets are non-negotiable at this stage. Our Global CRO capabilities support complex Phase III data management with the governance and quality focus that registration programs demand.
Learn moreClinical Data Management Expertise Across Complex Therapeutic Areas
Disease-specific Clinical Data Management strengthens database design, endpoint management and regulatory submissions across complex therapeutic areas. Biomarker datasets, rare disease programs and advanced therapy requirements all demand therapeutic knowledge where data complexity is greatest.
Oncology CRO
Oncology studies generate complex datasets including biomarker data, imaging assessments and multi-arm efficacy endpoints. Disease-specific database design, specialist coding and rigorous quality management are essential to producing the submission-ready data that oncology regulatory submissions require.
Learn moreRare Disease CRO
Rare disease programs involve small patient populations where every data point carries greater weight. Specialist coding, orphan drug regulatory compliance and meticulous data quality management are critical to maintaining the integrity of datasets collected across dispersed, specialist sites.
Learn moreNeurology CRO
Neurological studies require expert management of long-term follow-up data, specialist cognitive assessments and patient-reported outcomes. Consistent endpoint data collection across complex, extended programs requires the disease-specific CDM expertise that generic approaches cannot provide.
Learn moreImmunology CRO
Immunology programs spanning autoimmune diseases and biologics require sophisticated data management strategies for complex endpoint datasets, biomarker data and multi-parameter assessments. Specialist CDM expertise ensures data integrity throughout complex immunology development programs.
Learn moreInflammation Clinical Trials
Inflammation clinical trials require robust data collection across multiple endpoints and patient-reported outcomes. Disease-specific database design and rigorous quality governance throughout the study lifecycle protect the data quality that inflammation submissions depend on.
Learn moreCell & Gene Therapy CRO
Advanced therapy programs generate highly specialized datasets with unique regulatory requirements. Expert CDM support, quality-focused data governance and regulatory-compliant data structures ensure ATMP development programs produce the submission-ready evidence that approval pathways demand.
Learn moreOrphan Drug Development
Orphan drug programs combine rare disease data complexity with unique regulatory submission requirements. Our CDM teams provide the specialist coding, quality management and regulatory knowledge that orphan designation programs require throughout development.
Learn moreSpecialist Scientific Expertise
The acquisition of ICRC-Weyer has significantly strengthened Evestia Clinical's scientific capabilities, bringing nearly three decades of specialist expertise in Clinical Data Management, Biostatistics, Medical Writing and Pharmacovigilance into the organization.
For sponsors, this translates directly into greater technical depth, more integrated scientific disciplines, enhanced submission support and stronger data quality processes. Sponsors gain access to a single organization with the breadth and depth of expertise that complex clinical development programs require.
The result is more cohesive scientific support throughout development, with experienced specialist teams across every function working in alignment towards the same submission objectives.
Integrated Data Management and Biostatistics Support
Successful regulatory submissions depend on close, continuous collaboration between Clinical Data Management and Biostatistics. These two functions share responsibility for the quality and integrity of the datasets that regulatory agencies base their decisions on.
When CDM and Biostatistics operate in isolation, coordination weakens. SAPs are developed without adequate input into database design, datasets require revision after lock, and statistical analyses reveal data issues that should have been addressed earlier.
At Evestia Clinical, closer collaboration strengthens database design, statistical planning and submission readiness throughout development. CDM and Biostatistics specialists work together from study design through to final reporting, improving data quality, CDISC-compliant dataset preparation and regulatory confidence throughout the program. For sponsors, this integration is a meaningful advantage at submission.
Why Sponsors Choose Evestia Clinical for Clinical Data Management
The data management partner chosen shapes the quality of every development decision and regulatory submission that follows. As a CRO for biotech companies, Evestia Clinical combines Clinical Data Managers, integrated Biostatistics expertise and submission-focused quality processes that support the scientific integrity program success depends on.
Experienced Data Management Professionals
Experienced Clinical Data Managers bring scientific understanding, regulatory knowledge and practical operational expertise throughout development. Sponsors gain scientific partners rather than outsourced data processing.
Leading EDC Platform Expertise
Proficiency across Medidata Rave, Veeva Vault CDMS and Zelta by Merative gives sponsors the flexibility to work within their preferred system or choose the most appropriate platform for their program requirements.
Integrated Biostatistics Support
CDM and Biostatistics working in close collaboration throughout the study lifecycle, from SAP development and data review through to CDISC-compliant dataset preparation and regulatory reporting: one integrated team, not two disconnected functions.
Submission Readiness Focus
Every data management decision is made with regulatory submission in mind. Quality-driven processes, CDISC-compliant datasets and audit-ready documentation strengthen submission readiness and support smoother regulatory review.
Therapeutic Area Expertise
Disease-specific knowledge across oncology, rare disease, neurology, immunology, cell and gene therapy and other complex areas ensures CDM strategies are built around the specific data requirements each program presents.
Flexible Delivery Models
Clinical Data Management available through our Full-Service CRO model or as dedicated embedded resource through our FSP Solutions. Sponsors access specialist expertise at the scale their program requires without expanding permanent internal teams.
Why Biotech Companies Outsource Clinical Data Management
Clinical programs are growing in complexity and regulatory data expectations are rising. Evestia Clinical provides experienced CDM specialists, leading technology expertise and scalable resource aligned with funding milestones and program timelines, so biotech sponsors can advance with confidence and focus on their science.
Operating as an embedded partner, Evestia Clinical gives biotech companies access to scalable CDM expertise, leading technology platforms and flexible resource aligned with funding milestones and program timelines. Available through our Full-Service CRO model or embedded FSP Solutions, teams provide scientific collaboration and capability without permanent headcount expansion.
Frequently Asked Questions About Clinical Data Management
Explore Related Clinical Development Services
Service Pages
Development Phases
Clinical Data Management Built Around Your Program
Reliable clinical data, submission-ready datasets and integrated Biostatistics support give sponsors the scientific confidence that development decisions and regulatory submissions require.
Whether through full-service Clinical Data Management, embedded FSP specialists or integrated data and statistical support via our Biotech CRO model, Evestia Clinical provides the expertise, flexible delivery and regulatory focus that complex programs require.